COVID-19

The program will award grants for training and development of educational resources for employees in high risk occupations who serve the public during emergencies and who need skills to protect their own health.

Gunda Siska, RPh, PharmD, discusses what she is doing as a hospital pharmacist to stay healthy.

Pennsylvania Governor Tom Wolf’s administration has decided that in-state and out-of-state health care providers can treat patients via telemedicine during the coronavirus disease 2019 pandemic.

Officials with the FDA have said they are beginning to see unauthorized test kits marketed for consumers to test for COVID-19 at home.

Hoth Therapeutics and Voltron Therapeutics will collaborate to develop the self-assembling vaccine technology as a means to aid patients at risk of being infected with COVID-19.

Katie Turner, CPhT, is a senior pharmacy technician at Walgreens.

The test can be used to identify large numbers of infected patients and asymptomatic carriers, which would help support containment efforts and slow the spread of the coronavirus disease 2019 (COVID-19).

Not enough people are taking seriously frequent recommendations to practice social distancing, he said.

The FDA has issued a new guidance to sponsors and health care providers regarding certain Risk Evaluation and Mitigation Strategy-required testing during the coronavirus disease 2019 pandemic.

The COVID-19 High Performance Computing Consortium is a partnership of federal government, tech industry, and academic leaders whose goal is to stop the virus.

Tim Ulbrich, PharmD, co-founder and CEO of Your Financial Pharmacist, explains how your finances may be affected by the coronavirus and how your can reinforce your financial situation.

The US Pharmacopeia (USP) is providing free technical assistance to developers of antiviral drugs and vaccines that will support the public health response to the coronavirus disease 2019 (COVID-19) pandemic.

Pharmacy Moms Group special task force develops guidelines as precautions are implemented amid the COVID-19 pandemic.

A new commentary suggests that public health leaders should guide world leaders through the coronavirus disease 2019 pandemic.

A report published noted that there are subpopulations of pediatric patients with COVID-19 who have an increased risk for more significant illness.

Steven C. Hoffart, PharmD, owner and operator of Magnolia Pharmacy in Magnolia, Texas, said his pharmacy had run out of prepared hand sanitizer when he saw a need for many people in his area.

More than 90% of physicians, nurses, and pharmacists are concerned about COVID-19 affecting their patients, whereas 68% of doctors and 67% of nurses feel they are reasonably prepared for a COVID-19 outbreak in their area.

Four out of 8 manufacturers of hydroxychloroquine, an anti-malarial drug that had shown some success treating the symptoms of the novel coronavirus (COVID-19), are already experiencing shortages.

A new report from the CDC has found that a significant portion of hospitalizations in the United States have come from younger adults.

The FDA has released a statement addressing the issue, stating that the organization is “not aware of scientific evidence connecting the use of NSAIDs, like ibuprofen, with worsening COVID-19 symptoms.”

CVS mistakenly sent unproven information to employees surrounding drinking warm water to combat the novel coronavirus.

Marilyn Bulloch, PharmD, BCPS, FCCM, shares her perspective of how the global COVID-19 pandemic is impacting pharmacy in her Alabama community.

As the COVID-19 pandemic continues, a key issue for pharmacists, other health care professionals, and patients is the potential for disruptions in the US medication supply chain.

Top news of the week from Pharmacy Times surrounding the novel coronavirus.

The General Pharmaceutical Council has made plans to temporarily re-register pharmacists and pharmacy technicians should the government launch a state of emergency due to the novel coronavirus.

Researchers in Australia tested blood samples at 4 different time points in an otherwise healthy adult woman who presented with COVID-19 and had mild-to-moderate symptoms requiring hospital admission.

This will be the first global study of tocilizumab in this setting and is expected to begin enrolling in early April, with a target of approximately 330 patients globally.

Chloroquine and remdesivir are not FDA-approved for a COVID-19 indications.

Although preventive measures may be largely the same for patients with cancer during the COVID-19, the pandemic could result in difficult treatment decisions.

Members of AHIP will take steps to ensure affordable access to COVID-19 testing and treatment, according to a statement from the company.